Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1482 Articles

Chris Lange | Jul 17, 2020 at 7:44 AM EDT

8 Coronavirus Stocks That Can Deliver Even More Upside Ahead

The number of COVID-19 cases continues to rise, which will only create more demand for coronavirus stocks. 24/7 Wall Street…

Chris Lange | Jul 13, 2020 at 11:31 AM EDT

Even More Optimism for COVID-19 Vaccines as 2 More Hit the Fast Track

Pfizer and BioNTech have progressed in their COVID-19 vaccine effort, according to the FDA. Two of the companies’ four coronavirus…

Trey Thoelcke | Jul 13, 2020 at 7:39 AM EDT

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers still favored Exxon, Pfizer and Microsoft above all other Dow stocks.

Jon C. Ogg | Jul 9, 2020 at 10:59 AM EDT

5 Undervalued Defensive Stocks Not Receiving Enough Credit for a Post-Coronavirus Recovery

24/7 Wall St. has identified five defensive stocks that must greatly improve before they are deemed expensive or fully valued…

Chris Lange | Jul 8, 2020 at 10:52 AM EDT

Why Pfizer’s Stock Could Rise 60% or More

Pfizer is among the current frontrunners for a COVID-19 vaccine, so why is its stock down 13% year to date?…

Chris Lange | Jul 7, 2020 at 8:55 AM EDT

5 Speculative COVID-19 Stocks That Could Still Surge

24/7 Wall Street has picked out a few of the best and brightest coronavirus stocks that could still see a…

Chris Lange | Jul 1, 2020 at 12:53 PM EDT

Meet the New Frontrunners in the Race for a COVID-19 Vaccine

Pfizer and BioNTech have been collaborating to produce a messenger RNA based vaccine for the past few months, and this…

Trey Thoelcke | Jun 25, 2020 at 6:15 AM EDT

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers still favored Exxon, Pfizer and Microsoft above all other Dow stocks.

Trey Thoelcke | Jun 10, 2020 at 6:55 AM EDT

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers still favored Exxon, Pfizer and Microsoft above all other Dow stocks.

Trey Thoelcke | May 28, 2020 at 7:20 AM EDT

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Exxon, Pfizer and Microsoft above all other Dow stocks.

Trey Thoelcke | May 12, 2020 at 7:05 AM EDT

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Exxon, Pfizer and Microsoft above all other Dow stocks. The…

Chris Lange | May 5, 2020 at 11:12 AM EDT

BioNTech and Pfizer Kick Off Human Trials for COVID-19 Vaccine

BioNTech and Pfizer stocks each made a handy gain on Monday after the companies announced the beginning of human trials…

Chris Lange | Apr 28, 2020 at 1:17 PM EDT

Why Pfizer and Merck Earnings Are Slowing the Dow

Merck and Pfizer reported their most recent quarterly results before the opening bell Tuesday. Although markets appear to be recovering,…

Chris Lange | Apr 27, 2020 at 12:13 PM EDT

What to Watch When Merck and Pfizer Report Tuesday Morning

Pharmaceutical giants Merck and Pfizer are expected to report their most recent quarterly results before the opening bell Tuesday.

Chris Lange | Apr 27, 2020 at 9:37 AM EDT

Big Pharma Short Sellers Can’t Make Up Their Minds

The April 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

1 … 21 22 23 24 25 … 99

Pfizer : PFE

All Pfizer Articles

8 Coronavirus Stocks That Can Deliver Even More Upside Ahead

Even More Optimism for COVID-19 Vaccines as 2 More Hit the Fast Track

The 5 Most Shorted Dow Stocks

5 Undervalued Defensive Stocks Not Receiving Enough Credit for a Post-Coronavirus Recovery

Why Pfizer’s Stock Could Rise 60% or More

5 Speculative COVID-19 Stocks That Could Still Surge

Meet the New Frontrunners in the Race for a COVID-19 Vaccine

The 5 Most Shorted Dow Stocks

The 5 Most Shorted Dow Stocks

The 5 Most Shorted Dow Stocks

The 5 Most Shorted Dow Stocks

BioNTech and Pfizer Kick Off Human Trials for COVID-19 Vaccine

Why Pfizer and Merck Earnings Are Slowing the Dow

What to Watch When Merck and Pfizer Report Tuesday Morning

Big Pharma Short Sellers Can’t Make Up Their Minds

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

Most Income Investors Have Never Heard of These 3 ETFs Paying Over 10 Percent Monthly

The Home Sale That Adds $5,880 a Year to a Retiree’s Medicare Premium Two Years Later

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

The Home Sale That Adds $5,880 a Year to a Retiree's Medicare Premium Two Years Later

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

Most Income Investors Have Never Heard of These 3 ETFs Paying Over 10 Percent Monthly

Pfizer : PFE

All Pfizer Articles

8 Coronavirus Stocks That Can Deliver Even More Upside Ahead

Even More Optimism for COVID-19 Vaccines as 2 More Hit the Fast Track

The 5 Most Shorted Dow Stocks

5 Undervalued Defensive Stocks Not Receiving Enough Credit for a Post-Coronavirus Recovery

Why Pfizer’s Stock Could Rise 60% or More

5 Speculative COVID-19 Stocks That Could Still Surge

Meet the New Frontrunners in the Race for a COVID-19 Vaccine

The 5 Most Shorted Dow Stocks

The 5 Most Shorted Dow Stocks

The 5 Most Shorted Dow Stocks

The 5 Most Shorted Dow Stocks

BioNTech and Pfizer Kick Off Human Trials for COVID-19 Vaccine

Why Pfizer and Merck Earnings Are Slowing the Dow

What to Watch When Merck and Pfizer Report Tuesday Morning

Big Pharma Short Sellers Can’t Make Up Their Minds

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

Most Income Investors Have Never Heard of These 3 ETFs Paying Over 10 Percent Monthly

The Home Sale That Adds $5,880 a Year to a Retiree’s Medicare Premium Two Years Later

Featured Reads

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

The Home Sale That Adds $5,880 a Year to a Retiree's Medicare Premium Two Years Later